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Congenital syphilis is a rare and serious disease that although preventable continues to be a major health-care problem [1]. Its presence reflects a failure of prenatal care delivery system, 
as well as syphilis control programs. It is an infectious disease caused 
by Treponema pallidum transmitted through sexual contact and 
newborn babies through transplacental route to an infected mother. 
Untreated pregnant women with primary and secondary syphilis and 
spirochetemia are more likely to transmit infection than women with 
latent infection. Transmission can occur throughout pregnancy and 
40% of affected fetuses die in the intrauterine or perinatal period [2]. 
Clinical manifestations of congenital infections are varied and involve 
multiple organ systems. Majority of the infants are asymptomatic at 
the time of birth, but if untreated; symptoms develop within weeks 
or months [3]. We present a neonate with congenital syphilis, 
asymptomatic at birth, and diagnosed with laboratory investigations.
CASE REPORT
A male neonate born to a G3P1A1L1 mother by full-term normal 
vaginal delivery. He was born to a non-consanguineous parents, 
with a birth weight of 3.8 kg.. Mother had an uneventful pregnancy, 
however, found to be venereal disease research laboratory (VDRL) 
positive. During her first pregnancy, mother was VDRL positive, the 
female baby was born, who was asymptomatic and VDRL negative 
at the time of birth and continued the same status till date. During 
the second pregnancy, the outcome was abortion. This time during 
the third pregnancy; VDRL was positive, but quantitative titers 
were not available. She was treated with Inj. benzathine penicillin 
before this pregnancy but repeat VDRL titer post-treatment was not 
available. No treatment was taken during the pregnancy.
The baby cried immediately after birth. On examination, vitals 
were stable; cry, tone, and activity were normal and no markers 
of syphilis were found on the clinical examination. The baby 
was taking breastfeeds normally and passing urine and stools 
adequately. On laboratory investigation, serum VDRL was reactive 
(1:256), T. pallidum hemagglutination assay (TPHA) was detected 
(1:160), and cerebrospinal fluid (CSF) VDRL was also reactive. 
After delivery, maternal VDRL was reactive (1:32) and TPHA was 
detected (1:1280). There was a 4-fold rise in neonatal VDRL titers. 
Other investigations in the neonate revealed normal hemogram, 
negative sepsis screen, normal liver, and renal function tests and 
negative results for hepatitis B surface antigen, anti-hepatitis 
C virus, and human immunodeficiency virus. Radiological 
investigations were normal with normal ultrasonography abdomen.
Diagnosis of congenital neurosyphilis was made based on 
positive serological tests. Neonate was managed with intravenous 
sodium benzylpenicillin G-50,000 U/kg/dose twice daily for 
7 days, then thrice daily for next 3 days and supportive therapy. 
During follow-up, the patient was asymptomatic, and CSF and 
serum VDRL were non-reactive after 6 months. Later, the mother 
was treated with Inj. benzathine penicillin as per guidelines and 
VDRL became non-reactive.
DISCUSSION
Diagnosis of congenital syphilis is made when the mother of an 
infant has a reactive treponemal test or non-treponemal serologic test 
with 4-fold higher titers than mother’s titers or characteristic clinical 
findings in the infant or when T. pallidum is demonstrated by dark-
field microscopy or immunofluorescence from placental, skin, or 
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umbilical lesions. Non-treponemal test such as VDRL test is useful 
for correlating disease activity. Titers rise when the disease is active 
and fall when treatment is adequate as in our case neonatal titers 
were 4-fold higher than the maternal titers before treatment. VDRL 
usually becomes non-reactive in 1 year for treated primary syphilis 
and in 2 years for treated secondary syphilis. In this case, it became 
non-reactive after 6 months. False-positive VDRL can occur in an 
uninfected infant due to passively transferred maternal antibody and 
is suggested when neonatal titers are less than maternal titers, but 
these passively transferred antibodies disappear by 3 months of age. 
Treponemal tests such as fluorescent treponemal antibody absorption 
test (FTA-ABS) are used for confirmation of positive results of 
VDRL. These tests remain positive for life, even when the patient is 
treated and hence cannot be used for monitoring treatment [4].
Early congenital syphilis is analogous to the secondary stage of 
acquired syphilis. Patients may present with hepatosplenomegaly, 
jaundice, elevated liver transaminases, lymphadenopathy, and 
Coomb’s negative hemolytic anemia may be seen. Thrombocytopenia 
due to platelet trapping in the spleen is common. The characteristic 
rash seen is mucocutaneous erythematous maculopapular lesions 
followed by desquamation over hands and feet. Rhinitis and 
condylomatous lesions over mucous membranes are common [2]. 
Bone involvement in the form of painful osteochondritis at wrists, 
elbows, ankles, and knees occurs frequently. Periostitis of long bones 
may be seen. CNS involvement, failure to thrive, chorioretinitis, and 
nephrotic syndrome may also be seen [2].
Late congenital syphilis results primarily from chronic 
inflammation of bone, teeth, and CNS. The bony prominence of 
the forehead (Olympian brow), thickening of the sternoclavicular 
portion of the clavicle, anterior bowing of the mid-portion of the tibia 
(saber shins), and scaphoid scapula are resulted due to persistent or 
recurrent periostitis. Peg-shaped upper central permanent incisors 
and notched enamel (Hutchison’s teeth) are common. Saddle nose 
due to syphilitic rhinitis and a perforated nasal septum can occur. 
Other features of late congenital syphilis are Juvenile paresis, 
Juvenile tabes dorsalis, aortitis, interstitial keratitis, eight nerve 
deafness, and Clutton’s joints [2]. Hutchinson’s triad is composed 
of interstitial keratitis, eight nerve deafness, and Hutchinson’s teeth.
As already stated, the majority of infants are asymptomatic at 
the time of birth as in this case report also. Kucinskiene et al. (2016) 
from Lithuania reported clinical variations in early symptomatic 
congenital syphilis in a case report. In their case report, neonate 
presented with rashes, blisters, and wound immediately after 
delivery [5]. Shah I (2005) reported a case with a delayed diagnosis 
of early congenital syphilis. The infant was diagnosed at 7 months 
of age due to characteristic skin lesions. The mother was diagnosed 
to be VDRL positive during pregnancy; however, the child was not 
investigated for same after birth and was subsequently diagnosed 
only much later in life [6]. Another case report from New Delhi 
(2007) reported a case of late congenital syphilis presented at the 
age of 13 years with palatal perforation [7].
CDC recommends treatment for following infants: (1) Born 
to mothers who had untreated syphilis at birth, (2) evidence of 
maternal relapse or reinfection, (3) evidence of active disease 
in infant, (4) radiologic evidence of syphilis, (5) reactive 
CSF-VDRL in infants, and (6) infant’s VDRL titer at least 4-fold 
greater than the mother’s titer. If maternal treatment is adequate 
and more than 1 month before delivery and if infant’s VDRL 
test represents passively transferred antibody, the infant does 
not require treatment and follow-up VDRL is recommended [7]. 
Since CSF VDRL is not very sensitive, all infants with a diagnosis 
of congenital syphilis should be treated with the regimen for 
neurosyphilis. Treatment consists of crystalline penicillin G 
(100,000–150,000 U/kg/day 12 h for 7 days and thereafter 8 hourly 
for total 10–14 days) or procaine penicillin (50,000 U/kg IM daily 
for 10–14 days). Treated infants should be followed serologically 
to confirm decreasing VDRL titers [8].
If congenital syphilis is to be targeted for elimination, new 
approaches are required. The true incidence must be determined, 
diagnostic measures improved and risk factors controlled. There 
is a need to reexamine the current policies related to antenatal 
care and steps must be taken to overcome all administrative 
and cultural barriers. Control measures must be based on 
mandatory antenatal screening in the first  trimester supported 
by treatment and partner notification with adequate follow-up. 
Antenatal care must be strengthened to ensure that there is no 
reinfection; by treating a sexual partner, promoting condom uses 
during pregnancy and counseling all women on how to prevent 
sexually transmitted infection. Only a substantial effort can make 
congenital syphilis a tragedy of the past.
CONCLUSION
We present a case of congenital syphilis in a neonate born to a 
VDRL-positive mother which highlights the importance of adequate 
antenatal screening to prevent the cases of congenital syphilis. 
There have been sporadic case reports of congenital syphilis in our 
country, but the exact disease burden is not very clear.
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